bioAffinity Technologies, Inc.(BIAF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BIAF bioAffinity Technologies, Inc.

Trading 07-22 15:58:04 EDT

0.7110

+0.0059

+0.84%

High0.7234	Low0.7000	Vol262.20K
Open0.7050	D1 Closing0.7051	Amplitude3.32%
Mkt Cap4.47M	Tradable Cap4.36M	Total Shares6.28M
T/O187.04K	T/O Rate4.27%	Tradable Shares6.14M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BIAF","market":"US","secType":"STK","nameCN":"bioAffinity Technologies, Inc.","latestPrice":0.711,"timestamp":1784750281709,"preClose":0.7051,"halted":0,"volume":262197,"delay":0,"changeRate":0.008367607431570013,"floatShares":6136257,"shares":6283061,"eps":-11.3182,"marketStatus":"Trading","change":0.0059,"latestTime":"07-22 15:58:04 EDT","open":0.705,"high":0.7234,"low":0.7,"amount":187042.4513217,"amplitude":0.033187,"askPrice":0.718,"askSize":4800,"bidPrice":0.7039,"bidSize":840,"shortable":3,"etf":0,"ttmEps":-11.3182,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1784750400000},"marketStatusCode":2,"adr":0,"listingDate":1662004800000,"exchange":"NASDAQ","adjPreClose":0.7051,"preHourTrading":{"tag":"盘前","latestPrice":0.7199,"preClose":0.7051,"latestTime":"09:26 EDT","volume":98299,"amount":70781.4040277,"timestamp":1784726785889,"change":0.0148,"changeRate":0.02099,"amplitude":0.097291},"postHourTrading":{"tag":"盘后","latestPrice":0.72,"preClose":0.7051,"latestTime":"19:34 EDT","volume":8659,"amount":6231.6388,"timestamp":1784676844785,"change":0.0149,"changeRate":0.021132,"amplitude":0.021132},"volumeRatio":2.896785},"requestUrl":"/m/hq/s/BIAF/tweets","defaultTab":"tweets","newsList":[{"id":"2653757052","title":"Bioaffinity Technologies - Tests Expected to be Offered as Laboratory Developed Tests Under Clia","url":"https://stock-news.laohu8.com/highlight/detail?id=2653757052","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653757052?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:08","pubTimestamp":1784722101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0IE:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAF","BIAFW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653057757","title":"Bioaffinity Technologies - Partners with Pictor to Develop Asthma and Copd Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2653057757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653057757?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:08","pubTimestamp":1784722101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0IE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649809449","title":"Bioaffinity Quarterly Cypath Lung Test Sales Double, up More than 200% Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2649809449","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649809449?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:46","pubTimestamp":1783428414,"startTime":"0","endTime":"0","summary":"bioAffinity quarterly CyPath Lung test sales double, up more than 200% year over yearbioAffinity Technologies reported Q2 2026 CyPath Lung test sales up more than 30% from Q1 2026, doubling to a new q","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDLb2WcXg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648567521","title":"Bioaffinity to Join Navref-hosted Webinar on Philips-led US Veterans Lung Screening Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2648567521","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648567521?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:20","pubTimestamp":1782854414,"startTime":"0","endTime":"0","summary":"bioAffinity to join NAVREF-hosted webinar on Philips-led US veterans lung screening programbioAffinity Technologies will join a NAVREF-hosted webinar on July 21, 2026, focused on lung health screening","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL5xlhTf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","4DX.AU","BK4139","BK7094"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645902239","title":"BioAffinity will present preclinical findings on small interfering RNAs","url":"https://stock-news.laohu8.com/highlight/detail?id=2645902239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645902239?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:09","pubTimestamp":1782130189,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies (BIAF) will present preclinical findings for a novel therapeutic approach that uses small interfering RNAs that kill squam...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-will-present-preclinical-findings-on-small-interfering-rnas-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-will-present-preclinical-findings-on-small-interfering-rnas-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645302464","title":"bioAffinity reports positive preclinical data for siRNA therapy targeting squamous, basal skin cancer cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2645302464","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645302464?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:01","pubTimestamp":1782129688,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies will present preclinical in vitro findings at the 2026 RNA Therapeutics  Symposium.The study showed its proprietary siRNA approach selectively killed or slowed squamous and basal skin cancer cells while sparing healthy skin cells.The results support development of a topical treatment strategy for two high-incidence skin cancers where surgery can leave residual disease or recurrence risk.No human testing has been conducted, with no FDA IND filed for the program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire  on June 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL2LPJmn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024521","title":"bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024521","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024521?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:00","pubTimestamp":1782129602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA2DKRNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644403855","title":"BioAffinity Technologies Closes $3.2 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2644403855","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644403855?lang=en_us&edition=fundamental","pubTime":"2026-06-19 01:25","pubTimestamp":1781803513,"startTime":"0","endTime":"0","summary":"BioAffinity Technologies  said Thursday it closed a public offering of 4 million common shares and pre-funded warrants at $0.80 apiece for gross proceeds of $3.2 million.Each pre-funded warrant is exercisable for one common share and is immediately exercisable, according to a statement.Price: 0.85, Change: +0.01, Percent Change: +1.62","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644038389","title":"bioAffinity Technologies closes USD 3.2 million follow-on offering priced at USD 0.8 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2644038389","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644038389?lang=en_us&edition=fundamental","pubTime":"2026-06-19 01:16","pubTimestamp":1781802978,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies closed a $3.2 million public offering of common stock.Issued 4,000,000 shares, or pre-funded warrants in lieu, priced at $0.80 per share or $0.793 per pre-funded warrant.Pre-funded warrants are immediately exercisable for one share, expiring only when fully exercised.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire  on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL1tn6pr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644388090","title":"bioAffinity Technologies Announces Closing of $3.2 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2644388090","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644388090?lang=en_us&edition=fundamental","pubTime":"2026-06-19 01:16","pubTimestamp":1781802960,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nTUA2V66KN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAFW","BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644741423","title":"bioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644741423","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644741423?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:54","pubTimestamp":1781704461,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies  shares fell 13% in Wednesday trading after it said it has priced a public offering of 4 million shares of common stock, or pre-funded warrants in lieu thereof, at $0.80 per share for gross proceeds of $3.2 million.The biotech firm said it expects the offering to close Thursday.Investors may instead purchase pre-funded warrants at $0.793 each, with each warrant exercisable for one share of common stock.Price: 0.83, Change: -0.12, Percent Change: -12.22","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644074198","title":"BioAffinity Technologies prices 4M shares at 80c in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2644074198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644074198?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:30","pubTimestamp":1781703010,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies (BIAF) priced a Public Offering of securities as described below for aggregate gross proceeds to the Company of $3.2M, bef...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-prices-4m-shares-at-80c-in-public-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-technologies-prices-4m-shares-at-80c-in-public-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644030749","title":"bioAffinity Technologies prices USD 3.2 million public offering at USD 0.8 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2644030749","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644030749?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:25","pubTimestamp":1781702716,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies priced a public offering expected to raise USD 3.2 million in gross proceeds.Deal includes 4,000,000 common shares or pre-funded warrants at USD 0.8 per share or USD 0.793 per warrant.Pre-funded warrants are immediately exercisable for one common share, expiring only when fully exercised.Closing is expected on or about June 18, 2026, subject to customary closing conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire  on June 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL31hmvr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644749728","title":"bioAffinity Technologies Announces Pricing of $3.2 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749728?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:25","pubTimestamp":1781702700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUAC0VXGN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAF","BIAFW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643650752","title":"BioAffinity announces webinar for program to advance veteran lung health","url":"https://stock-news.laohu8.com/highlight/detail?id=2643650752","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643650752?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:12","pubTimestamp":1781611921,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies (BIAF) announced a webinar on July 21, 2026, featuring clinical experts discussing emerging approaches to lung health scre...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioaffinity-announces-webinar-for-program-to-advance-veteran-lung-health-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioaffinity-announces-webinar-for-program-to-advance-veteran-lung-health-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643095754","title":"bioAffinity Technologies to host veteran lung health screening webinar with Philips, 4DMedical","url":"https://stock-news.laohu8.com/highlight/detail?id=2643095754","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643095754?lang=en_us&edition=fundamental","pubTime":"2026-06-16 20:06","pubTimestamp":1781611578,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies will host a lung health screening webinar for U.S. veterans on July 21, 2026 at 6 p.m. ET.Session will highlight lung cancer screening approaches, imaging advances, noninvasive diagnostics such as CyPath Lung, access to follow-up care.Webinar features speakers from Philips, 4DMedical, RWJBarnabas Health; NAVREF’s Rashi Romanoff will moderate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire  on June 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL7lTMGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BIAF","BK7094","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643215337","title":"BRIEF-Bioaffinity Technologies - Offers 2.63 Million Shares Of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643215337","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643215337?lang=en_us&edition=fundamental","pubTime":"2026-06-13 06:01","pubTimestamp":1781301712,"startTime":"0","endTime":"0","summary":"BRIEF-Bioaffinity Technologies - Offers 2.63 Million Shares Of Common Stock - SEC FilingJune 12  - bioAffinity Technologies Inc BIAF.O:BIOAFFINITY TECHNOLOGIES - OFFERS 2.63 MILLION SHARES OF COMMON STOCK - SEC FILINGBIOAFFINITY TECHNOLOGIES - ASSUMED PUBLIC OFFERING PRICE SET AT $1.52 PER SHARE - SEC FILINGSource text: [ID:n0001493152-26-028507]Further company coverage: BIAF.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643627213","title":"bioAffinity Technologies - Offers 2.63 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643627213","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643627213?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:10","pubTimestamp":1781298651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BIAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643213605","title":"bioAffinity Technologies - Assumed Public Offering Price Set at $1.52 per Share - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643213605","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643213605?lang=en_us&edition=fundamental","pubTime":"2026-06-13 05:10","pubTimestamp":1781298651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nFWN42K0KB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640100879","title":"bioAffinity to present CyPath Lung test in Society for Advanced Bronchoscopy webinar","url":"https://stock-news.laohu8.com/highlight/detail?id=2640100879","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640100879?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:03","pubTimestamp":1780401829,"startTime":"0","endTime":"0","summary":"bioAffinity Technologies to join a Society for Advanced Bronchoscopy webinar on CyPath Lung testing on June 16 at 7 p.m. ET.Session to address use of the noninvasive test to risk-stratify indeterminate lung nodules, supporting early-stage detection and post-treatment surveillance.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLb1NBW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIAF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioaffinitytech.com;ir.bioaffinitytech.com","stockEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":-0.1578},{"period":"3month","weight":-0.7191},{"period":"6month","weight":-0.4815},{"period":"1year","weight":-0.9356},{"period":"ytd","weight":-0.4025}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0021},{"period":"3month","weight":0.0521},{"period":"6month","weight":0.0861},{"period":"1year","weight":0.1901},{"period":"ytd","weight":0.0973}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.125018},{"month":2,"riseRate":0.25,"avgChangeRate":-0.070787},{"month":3,"riseRate":0.5,"avgChangeRate":0.528916},{"month":4,"riseRate":0.75,"avgChangeRate":0.175283},{"month":5,"riseRate":0,"avgChangeRate":-0.203542},{"month":6,"riseRate":0.25,"avgChangeRate":-0.147014},{"month":7,"riseRate":0.5,"avgChangeRate":0.021659},{"month":8,"riseRate":0,"avgChangeRate":-0.216971},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.17769},{"month":10,"riseRate":0.25,"avgChangeRate":-0.105345},{"month":11,"riseRate":0.25,"avgChangeRate":-0.068737},{"month":12,"riseRate":0,"avgChangeRate":-0.246482}],"exchange":"NASDAQ","name":"bioAffinity Technologies, Inc.","nameEN":"bioAffinity Technologies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"bioAffinity Technologies, Inc.(BIAF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest bioAffinity Technologies, Inc.(BIAF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"bioAffinity Technologies, Inc.,BIAF,bioAffinity Technologies, Inc.股票,bioAffinity Technologies, Inc.股票老虎,bioAffinity Technologies, Inc.股票老虎国际,bioAffinity Technologies, Inc.行情,bioAffinity Technologies, Inc.股票行情,bioAffinity Technologies, Inc.股价,bioAffinity Technologies, Inc.股市,bioAffinity Technologies, Inc.股票价格,bioAffinity Technologies, Inc.股票交易,bioAffinity Technologies, Inc.股票购买,bioAffinity Technologies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"bioAffinity Technologies, Inc.(BIAF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest bioAffinity Technologies, Inc.(BIAF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}